BOSTON & BASEL, Switzerland (BUSINESS WIRE) Ironwood Pharmaceuticals, Inc. (“Ironwood”) (Nasdaq: IRWD), a GI-focused healthcare company, and VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a global clinical-stage biopharmaceutical company pioneering novel, transformational treatments for severe rare gastrointes.
Shares of VectivBio Holding AG (NASDAQ:VECT – Get Rating) reached a new 52-week high during trading on Thursday . The stock traded as high as $16.85 and last traded at $16.75, with a volume of 104461 shares trading hands. The stock had previously closed at $16.72. Analysts Set New Price Targets Several analysts have recently […]
/PRNewswire/ Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws.